European Companies Search Engine
EU funding (€244,894): Signalling of Minor Pocket Agonists at CXCR4 Hor23 Aug 2022 EU Research and Innovation programme "Horizon"
Overview
Text
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Sanofi-Aventis Recherche et Developpement SA, Gentilly, France.
The visualizations for "Sanofi-Aventis Recherche & Developpement - EU funding (€244,894): Signalling of Minor Pocket Agonists at CXCR4"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
